nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—GRIN1—telencephalic ventricle—brain cancer	0.0244	0.047	CbGeAlD
Amantadine—GRIN2B—telencephalic ventricle—brain cancer	0.0232	0.0448	CbGeAlD
Amantadine—DDC—telencephalic ventricle—brain cancer	0.019	0.0366	CbGeAlD
Amantadine—DDC—pineal body—brain cancer	0.0165	0.0318	CbGeAlD
Amantadine—GRIN1—ganglion—brain cancer	0.0152	0.0293	CbGeAlD
Amantadine—GRIN2B—ganglion—brain cancer	0.0145	0.0279	CbGeAlD
Amantadine—GRIN2C—hindbrain—brain cancer	0.0139	0.0268	CbGeAlD
Amantadine—GRIN2D—hindbrain—brain cancer	0.0129	0.0249	CbGeAlD
Amantadine—GRIN2A—ganglion—brain cancer	0.0126	0.0244	CbGeAlD
Amantadine—DDC—ganglion—brain cancer	0.0118	0.0228	CbGeAlD
Amantadine—GRIN1—hindbrain—brain cancer	0.0115	0.0222	CbGeAlD
Amantadine—GRIN2B—hindbrain—brain cancer	0.011	0.0212	CbGeAlD
Amantadine—GRIN2A—hindbrain—brain cancer	0.00959	0.0185	CbGeAlD
Amantadine—DDC—hindbrain—brain cancer	0.00896	0.0173	CbGeAlD
Amantadine—DRD2—telencephalic ventricle—brain cancer	0.00824	0.0159	CbGeAlD
Amantadine—GRIN2C—brainstem—brain cancer	0.00795	0.0153	CbGeAlD
Amantadine—GRIN2D—brainstem—brain cancer	0.00739	0.0143	CbGeAlD
Amantadine—GRIN2C—telencephalon—brain cancer	0.00706	0.0136	CbGeAlD
Amantadine—Disorientation—Lomustine—brain cancer	0.00705	0.0146	CcSEcCtD
Amantadine—SLC22A1—ganglion—brain cancer	0.00687	0.0133	CbGeAlD
Amantadine—Visual disturbance—Lomustine—brain cancer	0.00666	0.0138	CcSEcCtD
Amantadine—GRIN1—brainstem—brain cancer	0.00659	0.0127	CbGeAlD
Amantadine—GRIN2D—telencephalon—brain cancer	0.00656	0.0127	CbGeAlD
Amantadine—Lethargy—Lomustine—brain cancer	0.00644	0.0134	CcSEcCtD
Amantadine—Osteoarthritis—Lomustine—brain cancer	0.00631	0.0131	CcSEcCtD
Amantadine—GRIN2B—brainstem—brain cancer	0.00629	0.0121	CbGeAlD
Amantadine—GRIN3A—telencephalon—brain cancer	0.00617	0.0119	CbGeAlD
Amantadine—MAOB—ganglion—brain cancer	0.00608	0.0117	CbGeAlD
Amantadine—Ataxia—Lomustine—brain cancer	0.00593	0.0123	CcSEcCtD
Amantadine—GRIN1—telencephalon—brain cancer	0.00585	0.0113	CbGeAlD
Amantadine—Dysarthria—Procarbazine—brain cancer	0.00583	0.0121	CcSEcCtD
Amantadine—Cerebration impaired—Temozolomide—brain cancer	0.00567	0.0118	CcSEcCtD
Amantadine—Visual acuity reduced—Temozolomide—brain cancer	0.00561	0.0116	CcSEcCtD
Amantadine—GRIN2B—telencephalon—brain cancer	0.00558	0.0108	CbGeAlD
Amantadine—GRIN2C—medulla oblongata—brain cancer	0.00555	0.0107	CbGeAlD
Amantadine—GRIN2A—brainstem—brain cancer	0.0055	0.0106	CbGeAlD
Amantadine—Nightmare—Procarbazine—brain cancer	0.00533	0.0111	CcSEcCtD
Amantadine—GRIN2D—medulla oblongata—brain cancer	0.00516	0.00995	CbGeAlD
Amantadine—DDC—brainstem—brain cancer	0.00513	0.00991	CbGeAlD
Amantadine—DRD2—ganglion—brain cancer	0.00513	0.00989	CbGeAlD
Amantadine—Hypokinesia—Carmustine—brain cancer	0.00511	0.0106	CcSEcCtD
Amantadine—Paranoia—Carmustine—brain cancer	0.00506	0.0105	CcSEcCtD
Amantadine—Coma—Procarbazine—brain cancer	0.00504	0.0105	CcSEcCtD
Amantadine—GRIN2A—telencephalon—brain cancer	0.00488	0.00941	CbGeAlD
Amantadine—Stupor—Carmustine—brain cancer	0.00462	0.0096	CcSEcCtD
Amantadine—MAOB—hindbrain—brain cancer	0.00461	0.00889	CbGeAlD
Amantadine—GRIN2D—spinal cord—brain cancer	0.0046	0.00887	CbGeAlD
Amantadine—Photosensitivity—Procarbazine—brain cancer	0.00456	0.00947	CcSEcCtD
Amantadine—DDC—telencephalon—brain cancer	0.00456	0.00879	CbGeAlD
Amantadine—Disorientation—Procarbazine—brain cancer	0.00448	0.00929	CcSEcCtD
Amantadine—GRIN2C—head—brain cancer	0.00439	0.00848	CbGeAlD
Amantadine—Visual impairment—Lomustine—brain cancer	0.00421	0.00873	CcSEcCtD
Amantadine—GRIN1—midbrain—brain cancer	0.0042	0.0081	CbGeAlD
Amantadine—GRIN1—spinal cord—brain cancer	0.0041	0.00791	CbGeAlD
Amantadine—Lethargy—Procarbazine—brain cancer	0.00409	0.00848	CcSEcCtD
Amantadine—GRIN2D—head—brain cancer	0.00409	0.00788	CbGeAlD
Amantadine—GRIN2C—central nervous system—brain cancer	0.00401	0.00774	CbGeAlD
Amantadine—GRIN2C—cerebellum—brain cancer	0.00392	0.00757	CbGeAlD
Amantadine—GRIN2B—spinal cord—brain cancer	0.00391	0.00754	CbGeAlD
Amantadine—DRD2—hindbrain—brain cancer	0.00389	0.0075	CbGeAlD
Amantadine—Alopecia—Lomustine—brain cancer	0.00386	0.008	CcSEcCtD
Amantadine—Disturbance in attention—Temozolomide—brain cancer	0.00385	0.00799	CcSEcCtD
Amantadine—GRIN3A—head—brain cancer	0.00384	0.00741	CbGeAlD
Amantadine—GRIN2A—medulla oblongata—brain cancer	0.00383	0.00739	CbGeAlD
Amantadine—Pulmonary oedema—Hydroxyurea—brain cancer	0.0038	0.00789	CcSEcCtD
Amantadine—Ataxia—Procarbazine—brain cancer	0.00377	0.00782	CcSEcCtD
Amantadine—GRIN2D—central nervous system—brain cancer	0.00373	0.0072	CbGeAlD
Amantadine—GRIN1—endocrine gland—brain cancer	0.00369	0.00712	CbGeAlD
Amantadine—Leukocytosis—Carmustine—brain cancer	0.00367	0.00762	CcSEcCtD
Amantadine—GRIN2D—cerebellum—brain cancer	0.00365	0.00703	CbGeAlD
Amantadine—GRIN1—head—brain cancer	0.00364	0.00703	CbGeAlD
Amantadine—Gait disturbance—Carmustine—brain cancer	0.00354	0.00734	CcSEcCtD
Amantadine—GRIN2B—endocrine gland—brain cancer	0.00352	0.00679	CbGeAlD
Amantadine—GRIN3A—central nervous system—brain cancer	0.00351	0.00677	CbGeAlD
Amantadine—GRIN2A—midbrain—brain cancer	0.0035	0.00676	CbGeAlD
Amantadine—GRIN2B—head—brain cancer	0.00347	0.0067	CbGeAlD
Amantadine—Disorientation—Hydroxyurea—brain cancer	0.00346	0.00719	CcSEcCtD
Amantadine—Dysphagia—Procarbazine—brain cancer	0.00346	0.00718	CcSEcCtD
Amantadine—Gait disturbance—Temozolomide—brain cancer	0.00342	0.00709	CcSEcCtD
Amantadine—GRIN2A—spinal cord—brain cancer	0.00342	0.00659	CbGeAlD
Amantadine—Leukopenia—Lomustine—brain cancer	0.0034	0.00706	CcSEcCtD
Amantadine—Sweating increased—Procarbazine—brain cancer	0.00337	0.007	CcSEcCtD
Amantadine—Renal failure acute—Hydroxyurea—brain cancer	0.00336	0.00697	CcSEcCtD
Amantadine—Urinary incontinence—Carmustine—brain cancer	0.00333	0.00692	CcSEcCtD
Amantadine—Depressed level of consciousness—Carmustine—brain cancer	0.00333	0.00692	CcSEcCtD
Amantadine—GRIN1—central nervous system—brain cancer	0.00332	0.00641	CbGeAlD
Amantadine—DDC—midbrain—brain cancer	0.00327	0.00631	CbGeAlD
Amantadine—GRIN1—cerebellum—brain cancer	0.00325	0.00627	CbGeAlD
Amantadine—Urinary incontinence—Temozolomide—brain cancer	0.00322	0.00669	CcSEcCtD
Amantadine—Depressed level of consciousness—Temozolomide—brain cancer	0.00322	0.00669	CcSEcCtD
Amantadine—GRIN2C—brain—brain cancer	0.00318	0.00615	CbGeAlD
Amantadine—GRIN2B—central nervous system—brain cancer	0.00317	0.00612	CbGeAlD
Amantadine—Photosensitivity reaction—Procarbazine—brain cancer	0.00316	0.00656	CcSEcCtD
Amantadine—Coma—Carmustine—brain cancer	0.00315	0.00655	CcSEcCtD
Amantadine—GRIN2B—cerebellum—brain cancer	0.0031	0.00598	CbGeAlD
Amantadine—GRIN2A—endocrine gland—brain cancer	0.00308	0.00594	CbGeAlD
Amantadine—GRIN2A—head—brain cancer	0.00304	0.00586	CbGeAlD
Amantadine—Mental disability—Carmustine—brain cancer	0.003	0.00622	CcSEcCtD
Amantadine—GRIN2D—brain—brain cancer	0.00296	0.00571	CbGeAlD
Amantadine—Anorexia—Lomustine—brain cancer	0.00296	0.00613	CcSEcCtD
Amantadine—Mental disability—Temozolomide—brain cancer	0.00289	0.00601	CcSEcCtD
Amantadine—DDC—endocrine gland—brain cancer	0.00287	0.00555	CbGeAlD
Amantadine—DDC—head—brain cancer	0.00284	0.00548	CbGeAlD
Amantadine—Body temperature increased—Carboplatin—brain cancer	0.0028	0.00581	CcSEcCtD
Amantadine—GRIN3A—brain—brain cancer	0.00278	0.00537	CbGeAlD
Amantadine—GRIN2A—central nervous system—brain cancer	0.00277	0.00535	CbGeAlD
Amantadine—Hallucination—Procarbazine—brain cancer	0.00276	0.00572	CcSEcCtD
Amantadine—GRIN2A—cerebellum—brain cancer	0.00271	0.00523	CbGeAlD
Amantadine—Decreased appetite—Lomustine—brain cancer	0.0027	0.00559	CcSEcCtD
Amantadine—Amnesia—Carmustine—brain cancer	0.00267	0.00554	CcSEcCtD
Amantadine—SLC22A1—telencephalon—brain cancer	0.00265	0.00511	CbGeAlD
Amantadine—MAOB—brainstem—brain cancer	0.00264	0.0051	CbGeAlD
Amantadine—GRIN1—brain—brain cancer	0.00264	0.00509	CbGeAlD
Amantadine—DDC—central nervous system—brain cancer	0.00259	0.005	CbGeAlD
Amantadine—Amnesia—Temozolomide—brain cancer	0.00258	0.00535	CcSEcCtD
Amantadine—GRIN2B—brain—brain cancer	0.00252	0.00486	CbGeAlD
Amantadine—Neutropenia—Hydroxyurea—brain cancer	0.0025	0.0052	CcSEcCtD
Amantadine—Arrhythmia—Procarbazine—brain cancer	0.00248	0.00514	CcSEcCtD
Amantadine—Body temperature increased—Lomustine—brain cancer	0.00245	0.00509	CcSEcCtD
Amantadine—SIGMAR1—telencephalon—brain cancer	0.00245	0.00473	CbGeAlD
Amantadine—Alopecia—Procarbazine—brain cancer	0.00245	0.00508	CcSEcCtD
Amantadine—Tension—Procarbazine—brain cancer	0.00237	0.00491	CcSEcCtD
Amantadine—Ataxia—Carmustine—brain cancer	0.00236	0.00489	CcSEcCtD
Amantadine—MAOB—telencephalon—brain cancer	0.00234	0.00452	CbGeAlD
Amantadine—Nervousness—Procarbazine—brain cancer	0.00234	0.00486	CcSEcCtD
Amantadine—Liver function test abnormal—Carmustine—brain cancer	0.00231	0.0048	CcSEcCtD
Amantadine—Ataxia—Temozolomide—brain cancer	0.00228	0.00473	CcSEcCtD
Amantadine—Tremor—Procarbazine—brain cancer	0.00226	0.00469	CcSEcCtD
Amantadine—DRD2—brainstem—brain cancer	0.00223	0.0043	CbGeAlD
Amantadine—GRIN2A—brain—brain cancer	0.0022	0.00425	CbGeAlD
Amantadine—Dysphagia—Carmustine—brain cancer	0.00217	0.00449	CcSEcCtD
Amantadine—Leukopenia—Procarbazine—brain cancer	0.00216	0.00448	CcSEcCtD
Amantadine—Cardiac failure congestive—Etoposide—brain cancer	0.00214	0.00443	CcSEcCtD
Amantadine—Hallucination—Hydroxyurea—brain cancer	0.00213	0.00443	CcSEcCtD
Amantadine—Dysphagia—Temozolomide—brain cancer	0.00209	0.00434	CcSEcCtD
Amantadine—Convulsion—Procarbazine—brain cancer	0.00209	0.00434	CcSEcCtD
Amantadine—Hypertension—Procarbazine—brain cancer	0.00208	0.00432	CcSEcCtD
Amantadine—DDC—brain—brain cancer	0.00206	0.00397	CbGeAlD
Amantadine—Anxiety—Procarbazine—brain cancer	0.00205	0.00425	CcSEcCtD
Amantadine—Sweating increased—Temozolomide—brain cancer	0.00204	0.00423	CcSEcCtD
Amantadine—Neutropenia—Carmustine—brain cancer	0.00202	0.0042	CcSEcCtD
Amantadine—Dry mouth—Procarbazine—brain cancer	0.00201	0.00417	CcSEcCtD
Amantadine—SIGMAR1—pituitary gland—brain cancer	0.00199	0.00385	CbGeAlD
Amantadine—Cardiac failure—Etoposide—brain cancer	0.00199	0.00412	CcSEcCtD
Amantadine—Confusional state—Procarbazine—brain cancer	0.00198	0.00412	CcSEcCtD
Amantadine—DRD2—telencephalon—brain cancer	0.00198	0.00382	CbGeAlD
Amantadine—Vomiting—Lomustine—brain cancer	0.00197	0.00409	CcSEcCtD
Amantadine—Oedema—Procarbazine—brain cancer	0.00197	0.00409	CcSEcCtD
Amantadine—Neutropenia—Temozolomide—brain cancer	0.00196	0.00406	CcSEcCtD
Amantadine—Angiopathy—Hydroxyurea—brain cancer	0.00195	0.00404	CcSEcCtD
Amantadine—SIGMAR1—medulla oblongata—brain cancer	0.00192	0.00371	CbGeAlD
Amantadine—Tachycardia—Procarbazine—brain cancer	0.00192	0.00399	CcSEcCtD
Amantadine—Photosensitivity reaction—Temozolomide—brain cancer	0.00191	0.00396	CcSEcCtD
Amantadine—MAOB—pituitary gland—brain cancer	0.00191	0.00368	CbGeAlD
Amantadine—Hyperhidrosis—Procarbazine—brain cancer	0.0019	0.00395	CcSEcCtD
Amantadine—Alopecia—Hydroxyurea—brain cancer	0.00189	0.00393	CcSEcCtD
Amantadine—Anorexia—Procarbazine—brain cancer	0.00188	0.00389	CcSEcCtD
Amantadine—Cardiac arrest—Etoposide—brain cancer	0.00184	0.00382	CcSEcCtD
Amantadine—MAOB—medulla oblongata—brain cancer	0.00184	0.00355	CbGeAlD
Amantadine—Nausea—Lomustine—brain cancer	0.00184	0.00382	CcSEcCtD
Amantadine—Hypotension—Procarbazine—brain cancer	0.00184	0.00382	CcSEcCtD
Amantadine—Insomnia—Procarbazine—brain cancer	0.00178	0.0037	CcSEcCtD
Amantadine—Paraesthesia—Procarbazine—brain cancer	0.00177	0.00367	CcSEcCtD
Amantadine—ABCB1—blood vessel—brain cancer	0.00176	0.0034	CbGeAlD
Amantadine—SIGMAR1—midbrain—brain cancer	0.00176	0.00339	CbGeAlD
Amantadine—Somnolence—Procarbazine—brain cancer	0.00175	0.00363	CcSEcCtD
Amantadine—Hallucination—Carmustine—brain cancer	0.00172	0.00358	CcSEcCtD
Amantadine—SIGMAR1—spinal cord—brain cancer	0.00172	0.00331	CbGeAlD
Amantadine—Decreased appetite—Procarbazine—brain cancer	0.00171	0.00355	CcSEcCtD
Amantadine—Oedema peripheral—Carmustine—brain cancer	0.00171	0.00354	CcSEcCtD
Amantadine—Fatigue—Procarbazine—brain cancer	0.0017	0.00352	CcSEcCtD
Amantadine—MAOB—midbrain—brain cancer	0.00168	0.00325	CbGeAlD
Amantadine—Constipation—Procarbazine—brain cancer	0.00168	0.00349	CcSEcCtD
Amantadine—Dysphagia—Etoposide—brain cancer	0.00167	0.00348	CcSEcCtD
Amantadine—SLC22A1—endocrine gland—brain cancer	0.00167	0.00323	CbGeAlD
Amantadine—Leukopenia—Hydroxyurea—brain cancer	0.00167	0.00347	CcSEcCtD
Amantadine—Visual impairment—Carmustine—brain cancer	0.00167	0.00347	CcSEcCtD
Amantadine—Hallucination—Temozolomide—brain cancer	0.00167	0.00346	CcSEcCtD
Amantadine—Urinary tract disorder—Temozolomide—brain cancer	0.00165	0.00343	CcSEcCtD
Amantadine—SLC22A1—head—brain cancer	0.00165	0.00318	CbGeAlD
Amantadine—Oedema peripheral—Temozolomide—brain cancer	0.00165	0.00342	CcSEcCtD
Amantadine—MAOB—spinal cord—brain cancer	0.00164	0.00317	CbGeAlD
Amantadine—Urethral disorder—Temozolomide—brain cancer	0.00164	0.00341	CcSEcCtD
Amantadine—Sweating increased—Etoposide—brain cancer	0.00163	0.00339	CcSEcCtD
Amantadine—Feeling abnormal—Procarbazine—brain cancer	0.00162	0.00337	CcSEcCtD
Amantadine—Eye disorder—Carmustine—brain cancer	0.00162	0.00336	CcSEcCtD
Amantadine—Convulsion—Hydroxyurea—brain cancer	0.00162	0.00336	CcSEcCtD
Amantadine—Visual impairment—Temozolomide—brain cancer	0.00161	0.00335	CcSEcCtD
Amantadine—DRD2—pituitary gland—brain cancer	0.00161	0.00311	CbGeAlD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00158	0.00328	CcSEcCtD
Amantadine—Neutropenia—Etoposide—brain cancer	0.00157	0.00325	CcSEcCtD
Amantadine—Eye disorder—Temozolomide—brain cancer	0.00157	0.00325	CcSEcCtD
Amantadine—Body temperature increased—Procarbazine—brain cancer	0.00156	0.00323	CcSEcCtD
Amantadine—Cardiac disorder—Temozolomide—brain cancer	0.00155	0.00323	CcSEcCtD
Amantadine—Arrhythmia—Carmustine—brain cancer	0.00155	0.00321	CcSEcCtD
Amantadine—Alopecia—Carmustine—brain cancer	0.00153	0.00318	CcSEcCtD
Amantadine—Oedema—Hydroxyurea—brain cancer	0.00152	0.00316	CcSEcCtD
Amantadine—Angiopathy—Temozolomide—brain cancer	0.00152	0.00315	CcSEcCtD
Amantadine—Mental disorder—Carmustine—brain cancer	0.00152	0.00315	CcSEcCtD
Amantadine—Mediastinal disorder—Temozolomide—brain cancer	0.00151	0.00313	CcSEcCtD
Amantadine—Malnutrition—Carmustine—brain cancer	0.00151	0.00313	CcSEcCtD
Amantadine—SLC22A1—central nervous system—brain cancer	0.00151	0.00291	CbGeAlD
Amantadine—Nervous system disorder—Hydroxyurea—brain cancer	0.00149	0.0031	CcSEcCtD
Amantadine—Alopecia—Temozolomide—brain cancer	0.00148	0.00307	CcSEcCtD
Amantadine—Skin disorder—Hydroxyurea—brain cancer	0.00148	0.00307	CcSEcCtD
Amantadine—MAOB—endocrine gland—brain cancer	0.00148	0.00285	CbGeAlD
Amantadine—Mental disorder—Temozolomide—brain cancer	0.00147	0.00305	CcSEcCtD
Amantadine—MAOB—head—brain cancer	0.00146	0.00282	CbGeAlD
Amantadine—Malnutrition—Temozolomide—brain cancer	0.00146	0.00303	CcSEcCtD
Amantadine—Anorexia—Hydroxyurea—brain cancer	0.00145	0.00301	CcSEcCtD
Amantadine—Hypersensitivity—Procarbazine—brain cancer	0.00145	0.00301	CcSEcCtD
Amantadine—Vision blurred—Carmustine—brain cancer	0.00142	0.00295	CcSEcCtD
Amantadine—DRD2—midbrain—brain cancer	0.00142	0.00274	CbGeAlD
Amantadine—Tremor—Carmustine—brain cancer	0.00141	0.00293	CcSEcCtD
Amantadine—Asthenia—Procarbazine—brain cancer	0.00141	0.00293	CcSEcCtD
Amantadine—Agranulocytosis—Etoposide—brain cancer	0.00139	0.00289	CcSEcCtD
Amantadine—Pruritus—Procarbazine—brain cancer	0.00139	0.00289	CcSEcCtD
Amantadine—Agitation—Carmustine—brain cancer	0.00139	0.00288	CcSEcCtD
Amantadine—Vision blurred—Temozolomide—brain cancer	0.00137	0.00285	CcSEcCtD
Amantadine—Tremor—Temozolomide—brain cancer	0.00137	0.00284	CcSEcCtD
Amantadine—SIGMAR1—cerebellum—brain cancer	0.00136	0.00263	CbGeAlD
Amantadine—Dyspnoea—Hydroxyurea—brain cancer	0.00136	0.00282	CcSEcCtD
Amantadine—Somnolence—Hydroxyurea—brain cancer	0.00135	0.00281	CcSEcCtD
Amantadine—Leukopenia—Carmustine—brain cancer	0.00135	0.0028	CcSEcCtD
Amantadine—Diarrhoea—Procarbazine—brain cancer	0.00135	0.0028	CcSEcCtD
Amantadine—Dyspepsia—Hydroxyurea—brain cancer	0.00134	0.00278	CcSEcCtD
Amantadine—Agitation—Temozolomide—brain cancer	0.00134	0.00278	CcSEcCtD
Amantadine—MAOB—central nervous system—brain cancer	0.00133	0.00257	CbGeAlD
Amantadine—Decreased appetite—Hydroxyurea—brain cancer	0.00132	0.00275	CcSEcCtD
Amantadine—Urinary tract disorder—Etoposide—brain cancer	0.00132	0.00275	CcSEcCtD
Amantadine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00132	0.00273	CcSEcCtD
Amantadine—Urethral disorder—Etoposide—brain cancer	0.00131	0.00273	CcSEcCtD
Amantadine—Fatigue—Hydroxyurea—brain cancer	0.00131	0.00273	CcSEcCtD
Amantadine—Convulsion—Carmustine—brain cancer	0.00131	0.00271	CcSEcCtD
Amantadine—Leukopenia—Temozolomide—brain cancer	0.00131	0.00271	CcSEcCtD
Amantadine—Hypertension—Carmustine—brain cancer	0.0013	0.0027	CcSEcCtD
Amantadine—Constipation—Hydroxyurea—brain cancer	0.0013	0.0027	CcSEcCtD
Amantadine—MAOB—cerebellum—brain cancer	0.0013	0.00251	CbGeAlD
Amantadine—Dizziness—Procarbazine—brain cancer	0.0013	0.0027	CcSEcCtD
Amantadine—Palpitations—Temozolomide—brain cancer	0.00129	0.00267	CcSEcCtD
Amantadine—Anxiety—Carmustine—brain cancer	0.00128	0.00266	CcSEcCtD
Amantadine—Convulsion—Temozolomide—brain cancer	0.00126	0.00262	CcSEcCtD
Amantadine—Hypertension—Temozolomide—brain cancer	0.00126	0.00261	CcSEcCtD
Amantadine—Feeling abnormal—Hydroxyurea—brain cancer	0.00126	0.00261	CcSEcCtD
Amantadine—Eye disorder—Etoposide—brain cancer	0.00125	0.0026	CcSEcCtD
Amantadine—Vomiting—Procarbazine—brain cancer	0.00125	0.0026	CcSEcCtD
Amantadine—DRD2—endocrine gland—brain cancer	0.00125	0.00241	CbGeAlD
Amantadine—Cardiac disorder—Etoposide—brain cancer	0.00124	0.00258	CcSEcCtD
Amantadine—Confusional state—Carmustine—brain cancer	0.00124	0.00258	CcSEcCtD
Amantadine—Rash—Procarbazine—brain cancer	0.00124	0.00258	CcSEcCtD
Amantadine—Dermatitis—Procarbazine—brain cancer	0.00124	0.00257	CcSEcCtD
Amantadine—Anxiety—Temozolomide—brain cancer	0.00124	0.00257	CcSEcCtD
Amantadine—Headache—Procarbazine—brain cancer	0.00123	0.00256	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00123	0.00256	CcSEcCtD
Amantadine—DRD2—head—brain cancer	0.00123	0.00238	CbGeAlD
Amantadine—Oedema—Carmustine—brain cancer	0.00123	0.00256	CcSEcCtD
Amantadine—Angiopathy—Etoposide—brain cancer	0.00122	0.00252	CcSEcCtD
Amantadine—Dry mouth—Temozolomide—brain cancer	0.00121	0.00252	CcSEcCtD
Amantadine—Mediastinal disorder—Etoposide—brain cancer	0.00121	0.00251	CcSEcCtD
Amantadine—Body temperature increased—Hydroxyurea—brain cancer	0.0012	0.0025	CcSEcCtD
Amantadine—Tachycardia—Carmustine—brain cancer	0.0012	0.00249	CcSEcCtD
Amantadine—Confusional state—Temozolomide—brain cancer	0.0012	0.00249	CcSEcCtD
Amantadine—SLC22A1—brain—brain cancer	0.0012	0.00231	CbGeAlD
Amantadine—Oedema—Temozolomide—brain cancer	0.00119	0.00247	CcSEcCtD
Amantadine—Anaphylactic shock—Temozolomide—brain cancer	0.00119	0.00247	CcSEcCtD
Amantadine—Alopecia—Etoposide—brain cancer	0.00118	0.00246	CcSEcCtD
Amantadine—Anorexia—Carmustine—brain cancer	0.00117	0.00244	CcSEcCtD
Amantadine—Nausea—Procarbazine—brain cancer	0.00117	0.00243	CcSEcCtD
Amantadine—Nervous system disorder—Temozolomide—brain cancer	0.00117	0.00242	CcSEcCtD
Amantadine—Skin disorder—Temozolomide—brain cancer	0.00116	0.0024	CcSEcCtD
Amantadine—Hypotension—Carmustine—brain cancer	0.00115	0.00239	CcSEcCtD
Amantadine—Hyperhidrosis—Temozolomide—brain cancer	0.00115	0.00239	CcSEcCtD
Amantadine—Anorexia—Temozolomide—brain cancer	0.00113	0.00235	CcSEcCtD
Amantadine—DRD2—central nervous system—brain cancer	0.00112	0.00217	CbGeAlD
Amantadine—Hypersensitivity—Hydroxyurea—brain cancer	0.00112	0.00233	CcSEcCtD
Amantadine—Insomnia—Carmustine—brain cancer	0.00111	0.00231	CcSEcCtD
Amantadine—Paraesthesia—Carmustine—brain cancer	0.00111	0.0023	CcSEcCtD
Amantadine—SIGMAR1—brain—brain cancer	0.0011	0.00213	CbGeAlD
Amantadine—DRD2—cerebellum—brain cancer	0.0011	0.00212	CbGeAlD
Amantadine—Dyspnoea—Carmustine—brain cancer	0.0011	0.00228	CcSEcCtD
Amantadine—Somnolence—Carmustine—brain cancer	0.00109	0.00227	CcSEcCtD
Amantadine—Asthenia—Hydroxyurea—brain cancer	0.00109	0.00227	CcSEcCtD
Amantadine—Insomnia—Temozolomide—brain cancer	0.00108	0.00223	CcSEcCtD
Amantadine—Decreased appetite—Carmustine—brain cancer	0.00107	0.00222	CcSEcCtD
Amantadine—Paraesthesia—Temozolomide—brain cancer	0.00107	0.00222	CcSEcCtD
Amantadine—Gastrointestinal disorder—Carmustine—brain cancer	0.00106	0.00221	CcSEcCtD
Amantadine—Dyspnoea—Temozolomide—brain cancer	0.00106	0.0022	CcSEcCtD
Amantadine—Somnolence—Temozolomide—brain cancer	0.00106	0.0022	CcSEcCtD
Amantadine—MAOB—brain—brain cancer	0.00106	0.00204	CbGeAlD
Amantadine—Constipation—Carmustine—brain cancer	0.00105	0.00219	CcSEcCtD
Amantadine—Dyspepsia—Temozolomide—brain cancer	0.00105	0.00217	CcSEcCtD
Amantadine—Leukopenia—Etoposide—brain cancer	0.00104	0.00217	CcSEcCtD
Amantadine—Diarrhoea—Hydroxyurea—brain cancer	0.00104	0.00216	CcSEcCtD
Amantadine—Decreased appetite—Temozolomide—brain cancer	0.00103	0.00215	CcSEcCtD
Amantadine—Gastrointestinal disorder—Temozolomide—brain cancer	0.00103	0.00213	CcSEcCtD
Amantadine—Fatigue—Temozolomide—brain cancer	0.00103	0.00213	CcSEcCtD
Amantadine—Constipation—Temozolomide—brain cancer	0.00102	0.00211	CcSEcCtD
Amantadine—Feeling abnormal—Carmustine—brain cancer	0.00101	0.00211	CcSEcCtD
Amantadine—Convulsion—Etoposide—brain cancer	0.00101	0.0021	CcSEcCtD
Amantadine—Hypertension—Etoposide—brain cancer	0.00101	0.00209	CcSEcCtD
Amantadine—Dizziness—Hydroxyurea—brain cancer	0.00101	0.00209	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000987	0.00205	CcSEcCtD
Amantadine—Feeling abnormal—Temozolomide—brain cancer	0.000981	0.00204	CcSEcCtD
Amantadine—Body temperature increased—Carmustine—brain cancer	0.000974	0.00202	CcSEcCtD
Amantadine—Vomiting—Hydroxyurea—brain cancer	0.000969	0.00201	CcSEcCtD
Amantadine—Rash—Hydroxyurea—brain cancer	0.000961	0.00199	CcSEcCtD
Amantadine—Confusional state—Etoposide—brain cancer	0.00096	0.00199	CcSEcCtD
Amantadine—Dermatitis—Hydroxyurea—brain cancer	0.00096	0.00199	CcSEcCtD
Amantadine—Headache—Hydroxyurea—brain cancer	0.000954	0.00198	CcSEcCtD
Amantadine—Anaphylactic shock—Etoposide—brain cancer	0.000952	0.00198	CcSEcCtD
Amantadine—Body temperature increased—Temozolomide—brain cancer	0.000941	0.00195	CcSEcCtD
Amantadine—Tachycardia—Etoposide—brain cancer	0.000929	0.00193	CcSEcCtD
Amantadine—Skin disorder—Etoposide—brain cancer	0.000925	0.00192	CcSEcCtD
Amantadine—Hyperhidrosis—Etoposide—brain cancer	0.000921	0.00191	CcSEcCtD
Amantadine—Anorexia—Etoposide—brain cancer	0.000908	0.00188	CcSEcCtD
Amantadine—Hypersensitivity—Carmustine—brain cancer	0.000907	0.00188	CcSEcCtD
Amantadine—Nausea—Hydroxyurea—brain cancer	0.000905	0.00188	CcSEcCtD
Amantadine—DRD2—brain—brain cancer	0.000893	0.00172	CbGeAlD
Amantadine—Hypotension—Etoposide—brain cancer	0.00089	0.00185	CcSEcCtD
Amantadine—Asthenia—Carmustine—brain cancer	0.000884	0.00183	CcSEcCtD
Amantadine—Hypersensitivity—Temozolomide—brain cancer	0.000877	0.00182	CcSEcCtD
Amantadine—Paraesthesia—Etoposide—brain cancer	0.000855	0.00177	CcSEcCtD
Amantadine—ABCB1—telencephalon—brain cancer	0.000855	0.00165	CbGeAlD
Amantadine—Asthenia—Temozolomide—brain cancer	0.000854	0.00177	CcSEcCtD
Amantadine—Dyspnoea—Etoposide—brain cancer	0.000849	0.00176	CcSEcCtD
Amantadine—Somnolence—Etoposide—brain cancer	0.000847	0.00176	CcSEcCtD
Amantadine—Diarrhoea—Carmustine—brain cancer	0.000843	0.00175	CcSEcCtD
Amantadine—Pruritus—Temozolomide—brain cancer	0.000842	0.00175	CcSEcCtD
Amantadine—Decreased appetite—Etoposide—brain cancer	0.000828	0.00172	CcSEcCtD
Amantadine—Gastrointestinal disorder—Etoposide—brain cancer	0.000822	0.00171	CcSEcCtD
Amantadine—Fatigue—Etoposide—brain cancer	0.000821	0.0017	CcSEcCtD
Amantadine—Dizziness—Carmustine—brain cancer	0.000814	0.00169	CcSEcCtD
Amantadine—Constipation—Etoposide—brain cancer	0.000814	0.00169	CcSEcCtD
Amantadine—Diarrhoea—Temozolomide—brain cancer	0.000814	0.00169	CcSEcCtD
Amantadine—Dizziness—Temozolomide—brain cancer	0.000787	0.00163	CcSEcCtD
Amantadine—Feeling abnormal—Etoposide—brain cancer	0.000785	0.00163	CcSEcCtD
Amantadine—Vomiting—Carmustine—brain cancer	0.000783	0.00163	CcSEcCtD
Amantadine—Rash—Carmustine—brain cancer	0.000776	0.00161	CcSEcCtD
Amantadine—Dermatitis—Carmustine—brain cancer	0.000776	0.00161	CcSEcCtD
Amantadine—Headache—Carmustine—brain cancer	0.000771	0.0016	CcSEcCtD
Amantadine—Vomiting—Temozolomide—brain cancer	0.000757	0.00157	CcSEcCtD
Amantadine—Body temperature increased—Etoposide—brain cancer	0.000753	0.00156	CcSEcCtD
Amantadine—Rash—Temozolomide—brain cancer	0.00075	0.00156	CcSEcCtD
Amantadine—Dermatitis—Temozolomide—brain cancer	0.00075	0.00156	CcSEcCtD
Amantadine—Headache—Temozolomide—brain cancer	0.000746	0.00155	CcSEcCtD
Amantadine—Nausea—Carmustine—brain cancer	0.000731	0.00152	CcSEcCtD
Amantadine—ABCB1—gonad—brain cancer	0.000713	0.00138	CbGeAlD
Amantadine—Nausea—Temozolomide—brain cancer	0.000707	0.00147	CcSEcCtD
Amantadine—Hypersensitivity—Etoposide—brain cancer	0.000702	0.00146	CcSEcCtD
Amantadine—ABCB1—pituitary gland—brain cancer	0.000696	0.00134	CbGeAlD
Amantadine—Asthenia—Etoposide—brain cancer	0.000683	0.00142	CcSEcCtD
Amantadine—Pruritus—Etoposide—brain cancer	0.000674	0.0014	CcSEcCtD
Amantadine—ABCB1—medulla oblongata—brain cancer	0.000672	0.0013	CbGeAlD
Amantadine—Diarrhoea—Etoposide—brain cancer	0.000652	0.00135	CcSEcCtD
Amantadine—Dizziness—Etoposide—brain cancer	0.00063	0.00131	CcSEcCtD
Amantadine—ABCB1—midbrain—brain cancer	0.000614	0.00118	CbGeAlD
Amantadine—Vomiting—Etoposide—brain cancer	0.000605	0.00126	CcSEcCtD
Amantadine—Rash—Etoposide—brain cancer	0.0006	0.00125	CcSEcCtD
Amantadine—Dermatitis—Etoposide—brain cancer	0.0006	0.00125	CcSEcCtD
Amantadine—ABCB1—spinal cord—brain cancer	0.000599	0.00116	CbGeAlD
Amantadine—Headache—Etoposide—brain cancer	0.000597	0.00124	CcSEcCtD
Amantadine—Nausea—Etoposide—brain cancer	0.000566	0.00117	CcSEcCtD
Amantadine—ABCB1—endocrine gland—brain cancer	0.000539	0.00104	CbGeAlD
Amantadine—ABCB1—head—brain cancer	0.000532	0.00103	CbGeAlD
Amantadine—ABCB1—central nervous system—brain cancer	0.000486	0.000938	CbGeAlD
Amantadine—ABCB1—cerebellum—brain cancer	0.000475	0.000917	CbGeAlD
Amantadine—ABCB1—brain—brain cancer	0.000386	0.000744	CbGeAlD
